Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Anti-H. Pylori Effect of Deep See Water

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Nuoroda įrašoma į mainų sritį
StatusasBaigta
Rėmėjai
National Taiwan University Hospital

Raktažodžiai

Santrauka

Deep sea water (DSW) is characterized by high purity, low temperature, high nutrients and minerals and is obtained from the water flows 200 meters under the surface of the sea. The inhibition of H. pylori growth by DSW has been demonstrated in vitro study. However, up to now, there is few randomized control study to evaluate the anti-bacterial effects of ingesting DSW in patients with H. pylori infection.
The aims of this study are:
1. to evaluate the anti-bacterial effects of ingesting DSW in patients with H. pylori infection;
2. to evaluate the patient adherence and adverse effects of ingesting DSW.

apibūdinimas

Patients having H. pylori-positive chronic gastritis with/without small erosions or peptic ulcer scars will be recruited. Before treatment, H. pylori infection status will be examined by endoscopy with biopsy or 13C-urea breath test (13C-UBT). All patients will receive 13C-UBT before treatment, at the end of 2 week's treatment and 4 weeks after termination of treatment. A computed generated random numbers sequence will be blocked (2:1; block sizes of six) into two groups, say A and B.

group A - ingesting DSW 200 cc four times a day (one hour before meal and bed time); group B - ingesting non-DSW drinking water 200 cc four times a day (one hour before meal and bed time).

To keep the study in double-blind model, the picture of package for DSW and non-DSW drinking water will be the same.

Prokinetics (metoclopramide 5 mg/tab 1 tid) and antacid (strocain tablet (oxethazaine 5 mg and polymigel 244 mg/tab) 1 tid) will be permitted for relieving the dyspeptic symptoms.

All patients will be asked to complete a questionnaire and to record symptoms and water/drug consumption daily during the treatment period. Post-treatment, the patients will be seen at the Outpatients Clinic to investigate patient adherence and adverse of treatment.

Datos

Paskutinį kartą patikrinta: 04/30/2014
Pirmasis pateikimas: 08/27/2013
Numatytas registravimas pateiktas: 08/27/2013
Pirmas paskelbtas: 09/01/2013
Paskutinis atnaujinimas pateiktas: 05/11/2014
Paskutinis atnaujinimas paskelbtas: 05/13/2014
Faktinė studijų pradžios data: 08/31/2013
Numatoma pirminio užbaigimo data: 11/30/2013
Numatoma studijų užbaigimo data: 01/31/2014

Būklė ar liga

Helicobacter Pylori Infection

Intervencija / gydymas

Drug: group A: DSW group

Fazė

Fazė 3

Rankų grupės

RankaIntervencija / gydymas
Experimental: group A: DSW group
ingesting DSW 200 cc four times a day (one hour before meal and bed time);
Drug: group A: DSW group
ingesting DSW 200 cc four times a day (one hour before meal and bed time)
Placebo Comparator: group B: non-DSW group
ingesting non-DSW drinking water 200 cc four times a day (one hour before meal and bed time).

Tinkamumo kriterijai

Amžius, tinkami studijuoti 20 Years Į 20 Years
Tinkamos studijoms lytysAll
Priima sveikus savanoriusTaip
Kriterijai

Inclusion Criteria:

- Patients having H. pylori-positive chronic gastritis with/without small erosions or peptic ulcer scars who are aged greater than 20 years and are willing to received anti-H. pylori treatment.

Exclusion Criteria:

- pregnant or nursing woman

- serious concomitant illness and malignant tumor of any kind

- serious bleeding from gastrointestinal tract

- previous gastric surgery

- receiving bismuth salts, Proton pump inhibitors, or antibiotics in the previous month.

Rezultatas

Pirminės rezultatų priemonės

1. to compare the efficacy of DSW and non-DSW drinking water as anti-H. pylori regimen [6 months]

The eradication rates (efficacy) will be evaluated by intention-to-treat (ITT) and per-protocol (PP) analysis.

Antrinės rezultatų priemonės

1. to compare the adverse effects and patient adherence of DSW and non-DSW drinking water as anti-H. pylori regimen [6 months]

The safety and patient adherence will be evaluated by the number of participant with adverse events and by counting unused medication after the treatment.

Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge